LifeMD, Inc.

Symbol: LFMD

NASDAQ

10.18

USD

Market price today

  • -15.1229

    P/E Ratio

  • 0.2296

    PEG Ratio

  • 410.93M

    MRK Cap

  • 0.00%

    DIV Yield

LifeMD, Inc. (LFMD) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.95%

Operating Profit Margin

-0.08%

Net Profit Margin

-0.16%

Return on Assets

-0.39%

Return on Equity

4.60%

Return on Capital Employed

-0.69%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceuticals - Retailers
CEO:Mr. Justin Schreiber
Full-time employees:207
City:New York
Address:236 Fifth Avenue
IPO:2008-01-29
CIK:0000948320

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

General Outlook

When we look at how much money they make before expenses, they keep 0.946% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.077%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.161%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.393% return, is a testament to LifeMD, Inc.'s adeptness in optimizing resource deployment. LifeMD, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 4.597%. Furthermore, the proficiency of LifeMD, Inc. in capital utilization is underscored by a remarkable -0.690% return on capital employed.

Stock Prices

LifeMD, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $12, while its low point bottomed out at $11.16. This variance in figures offers investors a lucid insight into the roller-coaster ride that is LifeMD, Inc.'s stock market.

Liquidity Ratios

Analyzing LFMD liquidity ratios reveals its financial health of the firm. The current ratio of 99.40% gauges short-term asset coverage for liabilities. The quick ratio (90.54%) assesses immediate liquidity, while the cash ratio (78.59%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio99.40%
Quick Ratio90.54%
Cash Ratio78.59%

Profitability Ratios

LFMD profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -14.32% underscores its earnings before tax deductions. The effective tax rate stands at 50.94%, revealing its tax efficiency. The net income per EBT, 112.17%, and the EBT per EBIT, 185.91%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -7.70%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-14.32%
Effective Tax Rate50.94%
Net Income per EBT112.17%
EBT per EBIT185.91%
EBIT per Revenue-7.70%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.99, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 2815.75% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding91
Days of Inventory Outstanding108
Operating Cycle120.70
Days of Payables Outstanding563
Cash Conversion Cycle-442
Receivables Turnover28.16
Payables Turnover0.65
Inventory Turnover3.39
Fixed Asset Turnover89.76
Asset Turnover2.45

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.42, and free cash flow per share, 0.25, depict cash generation on a per-share basis. The cash per share value, 0.89, showcases liquidity position. A payout ratio of -0.13 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.11, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.42
Free Cash Flow per Share0.25
Cash per Share0.89
Payout Ratio-0.13
Operating Cash Flow Sales Ratio0.11
Free Cash Flow to Operating Cash Flow Ratio0.58
Cash Flow Coverage Ratio0.84
Short Term Coverage Ratio3.68
Capital Expenditure Coverage Ratio2.40
Dividend Paid and Capex Coverage Ratio1.66
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 32.39%, highlights its total liabilities relative to assets. With a debt-equity ratio of -23.55, we discern the balance between debt and equity financing. The long-term debt to capitalization, 105.82%, and total debt to capitalization, 104.44%, ratios shed light on its capital structure. An interest coverage of -6.24 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio32.39%
Debt Equity Ratio-23.55
Long Term Debt to Capitalization105.82%
Total Debt to Capitalization104.44%
Interest Coverage-6.24
Cash Flow to Debt Ratio0.84
Company Equity Multiplier-72.70

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.50, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.61, reflects the portion of profit attributed to each share. The book value per share, 0.10, represents the net asset value distributed per share, while the tangible book value per share, -0.27, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.50
Net Income Per Share-0.61
Book Value Per Share0.10
Tangible Book Value Per Share-0.27
Shareholders Equity Per Share0.10
Interest Debt Per Share0.63
Capex Per Share-0.26

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 28.15%, indicates top-line expansion, while the gross profit growth, 25.56%, reveals profitability trends. EBIT growth, 63.49%, and operating income growth, 63.49%, offer insights into operational profitability progression. The net income growth, 54.25%, showcases bottom-line expansion, and the EPS growth, 57.93%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth28.15%
Gross Profit Growth25.56%
EBIT Growth63.49%
Operating Income Growth63.49%
Net Income Growth54.25%
EPS Growth57.93%
EPS Diluted Growth57.93%
Weighted Average Shares Growth9.45%
Weighted Average Shares Diluted Growth9.45%
Dividends per Share Growth-8.64%
Operating Cash Flow Growth138.46%
Free Cash Flow Growth100.24%
10-Year Revenue Growth per Share3169.98%
5-Year Revenue Growth per Share377.67%
3-Year Revenue Growth per Share72.22%
10-Year Operating CF Growth per Share689.93%
5-Year Operating CF Growth per Share353.89%
3-Year Operating CF Growth per Share130.61%
10-Year Net Income Growth per Share-1230.37%
5-Year Net Income Growth per Share-332.65%
3-Year Net Income Growth per Share85.67%
10-Year Shareholders Equity Growth per Share210.72%
5-Year Shareholders Equity Growth per Share1.78%
3-Year Shareholders Equity Growth per Share9.01%
Receivables Growth86.16%
Inventory Growth-25.47%
Asset Growth127.85%
Book Value per Share Growth146.89%
Debt Growth358.69%
R&D Expense Growth104.04%
SGA Expenses Growth2.25%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 266,859,362.95, captures the company's total value, considering both debt and equity. Income quality, -0.43, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.34, gauges operational efficiency, while the research and development to revenue, 3.97%, highlights investment in innovation. The ratio of intangibles to total assets, 25.32%, indicates the value of non-physical assets, and capex to operating cash flow, -99.01%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value266,859,362.95
Income Quality-0.43
Sales General and Administrative to Revenue0.34
Research and Development to Revenue3.97%
Intangibles to Total Assets25.32%
Capex to Operating Cash Flow-99.01%
Capex to Revenue-5.72%
Capex to Depreciation-132.32%
Stock-Based Compensation to Revenue8.19%
Graham Number1.19
Return on Tangible Assets-47.16%
Graham Net Net-0.43
Working Capital7,822,543
Tangible Asset Value-9,239,083
Net Current Asset Value-10,310,283
Invested Capital5
Average Receivables4,056,000
Average Payables10,595,824
Average Inventory3,231,647.5
Days Sales Outstanding13
Days Payables Outstanding152
Days of Inventory On Hand38
ROIC-66.38%
ROE-5.88%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -431.74, and the price to book ratio, -431.74, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.53, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 39.14, and price to operating cash flows, 21.94, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-431.74
Price to Book Ratio-431.74
Price to Sales Ratio2.53
Price Cash Flow Ratio21.94
Price Earnings to Growth Ratio0.23
Enterprise Value Multiple-62.36
Price Fair Value-431.74
Price to Operating Cash Flow Ratio21.94
Price to Free Cash Flows Ratio39.14
Price to Tangible Book Ratio80.18
Enterprise Value to Sales1.75
Enterprise Value Over EBITDA-33.83
EV to Operating Cash Flow30.26
Earnings Yield-7.33%
Free Cash Flow Yield0.03%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of LifeMD, Inc. (LFMD) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -15.123 in 2024.

What is the ticker symbol of LifeMD, Inc. stock?

The ticker symbol of LifeMD, Inc. stock is LFMD.

What is company IPO date?

IPO date of LifeMD, Inc. is 2008-01-29.

What is company current share price?

Current share price is 10.180 USD.

What is stock market cap today?

The market cap of stock today is 410925880.000.

What is PEG ratio in 2024?

The current 0.230 is 0.230 in 2024.

What is the number of employees in 2024?

In 2024 the company has 207.